STOCKHOLM, Sweden — A proactive treat-to-target strategy in patients with Crohn's disease (CD) who are in remission but are considered to be high-risk as determined by video capsule endoscopy was ...

Researchers suggest capsule endoscopy should be the first-line modality for detecting small bowel Crohn’s disease in patients without endoscopic or clinical suspicion of stenosis, according to an ...

The Helmsley Charitable Trust issued a $3,035,566 grant to three researchers to explore the effects of GLP-1s, including Ozempic and Wegovy, on patients with Crohn’s disease. The effort will be led by ...

The oral cavity may be involved (ie, with ulcers), but the esophagus and pharynx are rarely involved. The antrum and duodenum are the most common sites involved in the upper gastrointestinal tract.

A new blood test may reveal Crohn’s disease years before symptoms begin. The test detects an unusual immune response to gut bacteria in people who later develop the condition. By studying healthy ...

Crohn’s Disease can affect any part of the gastrointestinal tract, but most commonly targets the terminal ileum and proximal colon. A key characteristic of Crohn’s is transmural involvement, meaning ...

Diagnosing and treating Crohn’s disease as early as possible can help prevent or stave off serious complications like perianal Crohn’s disease and colon cancer.

Stelara is a biologic medicine used to treat moderate to severe Crohn’s disease and ulcerative colitis. Crohn’s disease and ulcerative colitis are inflammatory bowel diseases that cause inflammation ...